Tumor-induced upregulation of the myeloid-related protein S100A8 and S100A9, which also can be produced by MDSCs, inhibit DCs differentiation from hematopoietic progenitor cells (HPCs) via persistent upregulation of ROS in progenitor cells and induced accumulation of MDSCs (40). Here, S100A8 is linked to neoplasm.